What does Kaleo do?
KALEO is a biopharmaceutical company that specializes in developing innovative therapies for opioid overdose and pain management. The company is known for its product, Narcan, a nasal spray that reverses opioid overdoses. KALEO is committed to improving patient access to its life-saving medications and advancing public health initiatives related to opioid use.
- Activities
- Signals
-
ProfitableProfitable € 66K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 5.56MStrong equity provides a buffer against setbacks.
Low riskLow risk 66.8%Good solvency (> 30%) points to long-term financial stability.
Positive cashflowPositive cashflow € 1.08MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 1.04MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 2.86MSubstantial turnover in the latest financial year.
Healthy social debtHealthy social debt 11.7%Social debts stay manageable relative to personnel costs.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Turnover
|
€
2.86M
|
|
|
|
|
€
3.97M
|
€
3.60M
|
€
3.20M
|
€
3.06M
|
|
|
€
1.04M
|
€
900K
|
€
718K
|
€
973K
|
|
|
€
66K
|
€
43K
|
€
-3K
|
€
187K
|
|
|
€
5.56M
|
€
4.93M
|
€
5.02M
|
€
5.37M
|
|
|
66.75%
|
65.14%
|
65.16%
|
68.36%
|
|
|
€
2.62M
|
€
2.48M
|
€
2.53M
|
€
2.33M
|
|
|
€
1.69M
|
€
1.77M
|
€
1.85M
|
€
2.79M
|
|
|
39.20
|
43.60
|
41.80
|
41.80
|
Publications 23
All publications- Demissions, Nominations 29/09/2026
- Demissions, Nominations 03/10/2025
- Demissions, Nominations 01/10/2024
- Demissions, Nominations 16/08/2023
- Demissions, Nominations 05/09/2022
Frequently asked questions
Answers to the most common questions about Kaleo, based on official government data and the filed annual accounts.
What is the VAT number of Kaleo?
The VAT number of Kaleo is BE0401.214.467.
How many employees work at Kaleo?
In 2025, Kaleo employed 39.20 full-time equivalents (FTE).
When was Kaleo established?
Kaleo was founded in 15-05-1937.
What is the official address of Kaleo?
The official address of Kaleo is Van Orleystraat 4 Brussel 1000.
What is the legal form of Kaleo?
The juridical form of Kaleo is Non-profit association (VZW/ASBL).
What is the annual revenue of Kaleo?
The revenue of Kaleo for the 2025 financial year was €2,862,448.
What does Kaleo do?
KALEO is a biopharmaceutical company that specializes in developing innovative therapies for opioid overdose and pain management. The company is known for its product, Narcan, a nasal spray that reverses opioid overdoses. KALEO is committed to improving patient access to its life-saving medications and advancing public health initiatives related to opioid use.
Is Kaleo a reliable company?
Kaleo is a registered Rechtspersoon with company number 0401.214.467 and can be verified through the official CBE database.
What is the credit limit of Kaleo?
The estimated credit limit of Kaleo is €1,672,855.
Is Kaleo still active?
Kaleo currently has the status "Normal situation" and is active.